NCT05377619View on ClinicalTrials.gov

Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

January 6, 2022

Primary Completion Date

March 6, 2022

Study Completion Date

March 6, 2022

Conditions
Dyspepsia
Interventions
DRUG

Prucalopride

prucalopride 2 mg 1 hour before the challenge with intake of wine (200 ml) and a dinner

DRUG

Buspirone

buspirone 10 mg 1 hour before the challenge with intake of wine (200 ml) and a dinner

DRUG

Placebo

placebo 1 hour before the challenge with intake of wine (200 ml) and a dinner

Trial Locations (1)

99010-080

University of Passo Fundo, Passo Fundo

All Listed Sponsors
lead

Universidade de Passo Fundo

OTHER

NCT05377619 - Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial | Biotech Hunter | Biotech Hunter